Bernardsville, NJ, United States of America

David Rampe

This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2005-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Rampe. Retrieved from https://idiyas.com/inventor/david-rampe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0


Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Journey of David Rampe

Introduction: David Rampe, a distinguished inventor hailing from Bernardsville, NJ, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: David Rampe holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for complex problems.

Career Highlights: With a career spanning over two decades, David Rampe has consistently pushed the boundaries of technological advancement, earning a reputation as a visionary inventor with a keen eye for detail and precision.

Collaborations: Throughout his career, David Rampe has collaborated with leading tech companies and research institutions, fostering a culture of innovation and knowledge-sharing to drive progress in the industry.

Conclusion: David Rampe's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his position as a trailblazing inventor, inspiring the next generation of innovators to dream big and think outside the box.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…